Inventor
JAMES D. RODGERS
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07BGeneral methods of organic chemistry20%
PatentTitleYear
11,744,832Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors202311,498,926Tricyclic heterocycles as BET protein inhibitors202211,331,320Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors202211,213,528Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to INCYTE CORP (4)· patent assignee history
2022–2023Patents assigned to INCYTE HOLDINGS CORP (4)· patent assignee history
2022Patents assigned to Incyte Cororation (1)· patent assignee history
2022–2023Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCYTE CORP | 4 | 2022–2023 |
| INCYTE HOLDINGS CORP | 4 | 2022–2023 |
| Incyte Cororation | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2023 |